Return On Equity in % of Calidi Biotherapeutics, Inc. from Q3 2023 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Calidi Biotherapeutics, Inc. quarterly/annual Return On Equity history and change rate from Q3 2023 to Q3 2025.
  • Calidi Biotherapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -432 %, a 282% decline year-over-year.
  • Calidi Biotherapeutics, Inc. annual Return On Equity for 2024 was 259 %, a 184% increase from 2023.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Calidi Biotherapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -432 -669 -282% 01 Jul 2025 30 Sep 2025
Q2 2025 -5.16K -5.42K -2078% 01 Apr 2025 30 Jun 2025
Q1 2025 651 +514 +375% 01 Jan 2025 31 Mar 2025
Q4 2024 259 +168 +184% 01 Oct 2024 31 Dec 2024
Q3 2024 237 +169 +251% 01 Jul 2024 30 Sep 2024
Q2 2024 261 01 Apr 2024 30 Jun 2024
Q1 2024 137 01 Jan 2024 31 Mar 2024
Q4 2023 91.2 01 Oct 2023 31 Dec 2023
Q3 2023 67.5 01 Jul 2023 30 Sep 2023

Calidi Biotherapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 259 +168 +184% 01 Jan 2024 31 Dec 2024
2023 91.2 01 Jan 2023 31 Dec 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.